Loading...
RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells
Zhang, Yong-Wei Nasto, Rochelle E. Jablonski, Sandra A. Serebriiskii, Ilya G. Surana, Rishi Murray, Joseph Johnson, Michael Riggins, Rebecca B. Clarke, Robert
Zhang, Yong-Wei
Nasto, Rochelle E.
Jablonski, Sandra A.
Serebriiskii, Ilya G.
Surana, Rishi
Murray, Joseph
Johnson, Michael
Riggins, Rebecca B.
Clarke, Robert
Citations
Altmetric:
Genre
Journal article
Date
2017-08-05
Advisor
Committee member
Department
Cancer and Cellular Biology
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.21769/bioprotoc.2435
Abstract
RNAi screening technology has revealed unknown determinants of various biological signaling pathways in biomedical studies. This protocol provided detailed information about how to use RNAi screening to identify proliferation determinants in breast tumor cells. siRNA-based libraries targeting against Estrogen receptor (ER)-network, including 631 genes relevant to estrogen signaling, was constructed for screening in breast cancer cells. Briefly, reverse transfection of siRNA induced transient gene knockdown in MCF7 cells. First, the transfection reagent for MCF7 cells was selected. Next, the Z’-score assay was used to monitor if screening conditions yielded efficiently. Then, the ER-network siRNA library screening was preceded by automatic machines under optimized experimental conditions.
Description
Citation
Zhang Y-W, Nasto RE, Jablonski SA, Serebriiskii IG, Surana R, Murray J, et al. RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio-protoc. 2017 Aug 5;7(15):e2435. doi:10.21769/BioProtoc.2435.
Citation to related work
Bio-Protocol
Has part
Bio-protocol, Vol. 7, Iss. 15
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu